|
|
Tuberculin Skin Tests
Test Overview
A tuberculin skin test is done to see if you have ever had
tuberculosis (TB) (Mycobacterium
tuberculosis). It is done by putting a small amount of TB protein (antigens) under the top layer of skin on your inner
forearm. If you have ever been exposed to the TB bacteria, your skin will react
to the antigens by developing a firm red bump at the site within 2 days.
The Mantoux skin test uses TB antigens called purified protein
derivative (PPD). The test cannot tell if the infection is active or inactive
(latent).
The Mantoux test uses a measured amount of PPD in a shot that is
put under the top layer of skin on your forearm. A Mantoux test is a good test
for a TB infection. It is often used when symptoms, screening, or testing, such
as a chest
X-ray, show that a person may have TB.
A tuberculin skin test cannot tell how long you have been infected
with TB or if the infection can be passed to others (active TB).
Why It Is Done
A tuberculin skin test is done to find people with tuberculosis
(TB), including:
- People who have been in close contact with
someone known to have TB.
- Health care workers who are likely to be
exposed to TB.
- People with TB symptoms, such as an ongoing cough,
night sweats, and weight loss for no reason.
- People who have had an
abnormal chest X-ray.
- People who have had a recent organ transplant
or with
impaired immune systems, such as those with
human immunodeficiency virus (HIV).
A tuberculin skin test should not be done for people who have
a:
- Known TB infection.
- Positive
tuberculin skin test in the past. A second test may cause a more severe
reaction to the TB antigens.
- Skin rash that would make it hard to
read the skin test.
How To Prepare
Before having a tuberculin skin test, tell your health professional
if you:
- Have symptoms of tuberculosis (TB), such as an
ongoing cough, night sweats, or weight loss for no reason.
- Have had
a positive tuberculin skin test in the past.
- Have had TB in the
past.
- Have risk factors for TB. Risk factors include:
- Contact with a person who has
TB.
- A job as a health care worker that may cause you to be exposed
to people with TB.
- Having lived or traveled in a country where TB
is common.
- Have been given a TB vaccination. The vaccine
contains a bacteria called BCG (bacille Calmette-Guérin) that is
closely related to the bacteria that cause TB.
- Have been treated
with medicines, such as
corticosteroids, that can affect your
immune system.
- Are infected with the human
immunodeficiency virus (HIV).
- Have a skin rash that may make it
hard to read the skin test.
Talk to your health professional about any concerns you have
regarding the need for the test, its risks, how it will be done, or what the
results will indicate. To help you understand the importance of this test, fill
out the
medical test
information form (What is a PDF document?).
How It Is Done
For a tuberculin skin test, you sit down and turn the inner side of
your forearm up. The skin where the test is done is cleaned and allowed to dry.
A small shot of the TB antigen (purified protein derivative, or PPD) is put
under the top layer of skin. The fluid makes a little bump (wheal) under the
skin. A circle may be drawn around the test area with a pen. See an
illustration of a person receiving a
Mantoux
test .
Do not cover the site with a bandage. You must see your health
professional 2 to 3 days after the test to have the skin test checked.
How It Feels
You may feel a quick sting or pinch from the needle.
Risks
There is a very slight risk of having a severe reaction to the
tuberculin skin test, especially if you have had tuberculosis (TB). An
allergic reaction can cause a lot of swelling and pain
at the site. A sore may be present.
You cannot get a TB infection from the tuberculin skin test,
because no live bacteria are used for the test.
After the test
Some redness at the skin test site is expected. The site may
itch, but it is important that you do not scratch it, since this may cause
redness or swelling that could make it hard to read the skin test. If itching
is a problem, put a cold washcloth on the site and then dry it.
A strong positive reaction may cause mild pain. Talk to your
health professional if you have:
- A fever.
- Swelling in your
arm.
- Swollen
lymph nodes in your armpit.
Results
A tuberculin skin test is done to see if you have ever had
tuberculosis (TB) (infection with
Mycobacterium tuberculosis).
Redness alone at the skin test site is a negative reaction meaning
you have not been infected with TB bacteria. A firm red bump is a positive
reaction to the skin test meaning you have been infected with TB bacteria at
some time. The size of the firm bump (not the red area) is measured 2 to 3 days
after the test to determine the result. Your doctor will consider your chance
of having TB when looking at the skin test site. See an illustration of the
measurement of a tuberculin skin test result .
Three levels of risk have been defined:
-
High-risk group includes
people with
human immunodeficiency virus (HIV), those who have had
close recent contact with a person who has an active TB infection, and those
who have symptoms or a chest
X-ray that shows TB. Other people at high risk for
tuberculosis include those who take medicines that contain
corticosteroids for a long time or people taking tumor
necrosis factor-alpha antagonists (used to treat
rheumatoid arthritis and
Crohn's disease).
-
Moderate-risk group includes people who have recently moved
from or traveled in a country with a high rate of TB; those who use illegal
drugs by injection (intravenous drug users); people who
live in nursing homes; workers in hospitals, nursing homes, schools, and
prisons; children younger than 4 years old; children (ages 4 to 18) who are
exposed to high-risk adults; and homeless people. Others at moderate risk for
having tuberculosis include people who are 10% or more below their ideal body
weight and people with
kidney failure,
diabetes,
leukemia, cancer, or those who have had part of their
stomach removed (gastrectomy).
-
Low-risk
group includes people who do not have any possible exposure to TB listed
in the other risk groups.
A positive reaction usually remains visible for about 1
week.
Mantoux tuberculin skin test
| Normal (negative
results): |
No firm bump forms at the test site, or a bump forms that
is smaller than 5 mm (0.2 in.).
|
|
Abnormal (positive results): |
A firm bump that is
5 mm (0.2 in.) in size shows a
TB infection in people who are in a high-risk group.
|
|
A firm bump that is
10 mm (0.4 in.) in size shows a
TB infection in people who are in a moderate-risk group.
|
|
A firm bump that is
15 mm (0.6 in.) in size shows a
TB infection in people who are in a low-risk group.
|
A positive tuberculin skin test does not mean you have a contagious
(active) infection. The test cannot tell if the infection is active or inactive
(latent TB). It also can not tell the difference between a TB infection and a
TB vaccination (BCG vaccination). More tests—such as a chest X-ray, a
sputum
culture, or both—are usually done to see if you have
an active TB infection.
What Affects the Test
Reasons you may not be able to have the test or why the results may
not be helpful include:
- A BCG (bacille Calmette-Guérin) vaccination. If
you have had a BCG vaccination, you may have a positive PPD skin
test.
- Taking medications that suppress the
immune system, such as
corticosteroids.
- Conditions that weaken the immune system, such as
an HIV infection or cancer. The result also may be affected if a person is
severely malnourished.
- Some vaccinations for infections, such as
measles,
mumps,
rubella,
polio, or
chickenpox, given within 6 weeks before the tuberculin
test. A recent infection with one of these viruses can also interfere with test
results for a short period of time. The skin test also may be positive if the
person has an infection caused by a mycobacterium other than the one that
causes TB.
- A very recent TB infection. It takes 2 to 10 weeks for
the immune system to react to TB bacteria.
- Age younger than 3
months old. A baby's immune system is not fully developed at this
age.
- A "booster effect." This tends to occur in people who get
regular TB skin tests, such as health care workers. The booster effect is a
weak or no reaction to one TB skin test followed by a strong reaction from a
second test. However, the strong reaction to the second test does not mean that
the person has just become infected with TB. Instead, the reaction may be due
to:
- A TB infection that occurred long ago. Over time, a
person's immune system tends to stop reacting strongly to the TB bacteria. So,
the first TB skin test stimulates (boosts) the immune system, which then reacts
strongly to the second skin test.
- The BCG vaccine, which contains
bacteria similar to the bacteria that cause TB. A person's immune system does
not react as strongly to the vaccine bacteria, and this tends to diminish over
time. So, the person's immune system is boosted by the first skin test and
reacts strongly to the second test.
- Infection with bacteria similar
to Mycobacterium tuberculosis. This may also cause a
first TB skin test to boost the immune system, allowing it to react strongly to
a second test, even though a new TB infection has not occurred.
What To Think About
- The results of a tuberculin skin test alone
cannot confirm an active TB infection. Other tests, such as a chest X-ray and
sputum culture, may be done to confirm an active TB
infection when a skin test is positive. A person who has a positive skin test
or chest X-ray, but no TB symptoms, is usually thought to have a TB infection
that cannot be passed to others (latent TB). For more information, see the
medical tests
Chest X-ray and
Sputum Culture.
- Among hospital workers or
others who have periodic skin tests, a second test done within a few weeks of a
negative test may be positive, even though the person was not infected between
the two tests. These results (called the booster effect) may indicate a
previous BCG vaccination or TB infection.
- About 5% of people who
have inactive TB will develop active TB in 2 years. Another 5% of people with
inactive TB will develop active TB in their lifetime. The chance of developing
active TB is higher in children, older adults, and people with an
impaired immune system.
- No more tests are
needed for a person with a negative Mantoux test who has no symptoms of active
infection and no history of being exposed to TB.
- Some people do not
react to a tuberculin skin test even if they have tuberculosis. Conditions such
as active TB, cancer, or
autoimmune deficiency syndrome (AIDS) do not always
respond normally to the TB antigens. In these cases, other skin tests may be
done. If there is a skin reaction, then the tuberculin skin test is probably
correct. However, if there is no reaction, the person's immune system is likely
to be too weak to respond normally to the tuberculin skin test.
- A
new blood test (called QuantiFERON-TB Gold) to diagnose TB has been approved by
the U.S. Food and Drug Administration (FDA). This test may be used instead of a
tuberculin skin test. For example, it can tell if a person reacted to a skin
test because of an active TB infection or a previous BCG vaccination. However,
this test is not yet widely done.
- A new rapid test (polymerase
chain reaction, or PCR) for tuberculin testing of sputum has been approved by
the U.S. Food and Drug Administration (FDA); however, more studies using this
test are needed before it can be widely used.
- For more information
about tuberculosis, see the topic
Tuberculosis (TB).
References
Other Works Consulted
-
Division of Tuberculosis Elimination, National Center
for HIV, STD, and TB Prevention (2002). Questions and Answers
About TB. Available online:
http://www.cdc.gov/nchstp/tb/faqs/qa.htm.
-
Centers for Disease Control and Prevention (2005).
Guidelines for using the QuantiFERON®-TB test for
diagnosing latent Mycobacterium tuberculosis infection.
MMWR, 54(RR-15): 49–55.
-
Small PM, Selcer UM (2000). Tuberculosis. In GT Strickland,
ed., Hunter's Tropical Medicine and Emerging Infectious Diseases, 8th ed., pp. 491–513. Philadelphia: W.B. Saunders.
Credits
| Author | Maria G. Essig, MS, ELS |
| Editor | Susan Van Houten, RN, BSN, MBA |
| Associate Editor | Tracy Landauer |
| Primary Medical Reviewer | E. Gregory Thompson, MD - Internal Medicine |
| Specialist Medical Reviewer | Alfred A. Lardizabal, MD - Pulmonology and Critical Care Medicine/Tuberculosis |
| Last Updated | May 18, 2007 |
|
|
| Author: | Maria G. Essig, MS, ELS | Last Updated: May 18, 2007 |
| Medical Review: | E. Gregory Thompson, MD - Internal Medicine
Alfred A. Lardizabal, MD - Pulmonology and Critical Care Medicine/Tuberculosis |
|
|
|
© 1995-2008, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|